One such example is the use of CRISPRa to upregulate the relaxin family peptide receptor 1 (RXFP1) gene in adipose-derived stem cells and their transplantation in a diabetes mellitus-induced erectile dysfunction rat model, showing amelioration of the erectile dysfunction phenotype86. This evidence concerns the gene RXFP1 and diabetes mellitus.